Montefiore and Einstein evaluate a new drug combination to fight COVID-19

NewsColony
Montefiore and Einstein evaluate a new drug combination to fight COVID-19

Reviewed by Emily Henderson, B.Sc.May 26 2020

Montefiore Health System Albert Einstein College of Medicine have begun the next stage of the Adaptive COVID-19 Treatment Trial (ACTT), to evaluate treatment options for people hospitalized with severe COVID-19 infection. The new iteration of the trial, known as ACTT 2, is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

In March, Montefiore was the first New York location to join the multicenter trial, which evaluated remdesivir, a broad-spectrum antiviral drug given intravenously. Preliminary results from the trial, announced last month and published on Friday in the New England Journal of Medicine, show that patients with COVID-19 who received remdesivir recovered in 11 days on average compared to 15 days for patients in the placebo group–a statistically significant improvement. Of the 1,063 clinical trial participants, 91 of them, nearly 10%, were from Montefiore and Einstein.

Following up on remdesivir’s promising results, the trial is now studying remdesivir in combination with baricitinib or placebo in a double-blind, randomized trial. Baricitinib is marketed for reducing inflammation associated with rheumatoid arthritis. Researchers want to know if baricitinib combined with remdesivir can prevent or reduce the hyper-inflammatory “cytokine storm” that can fatally overwhelm the lungs and other parts of the body in people with COVID-19 when their immune system reacts to coronavirus infection.

What concerns us is that in some people the immune response to coronavirus can be more deadly than the infection itself, and there is no known treatment for this yet. Including baricitinib in our trial may reduce COVID-19-related inflammation and combining baricitinib with remdesivir may yield an even more effective treatment option for people most severely affected by this illness.”

Barry Zingman, M.D., professor of medicine at Einstein and clinical director, infectious diseases, at the Moses division of Montefiore Health System

Dr. Zingman oversaw the original remdesivir study at Montefiore and is directing ACTT 2.

Patients enrolled in ACTT 2 are hospitalized with a laboratory-confirmed coronavirus infection and lung complications, including rattling sounds when breathing, a need for supplemental oxygen, abnormal chest X-rays showing pneumonia, or the need for a mechanical ventilator. All patients will receive remdesivir intravenously for up to 10 days. Half of the patients will also be given baricitinib by mouth, with the remaining half receiving an identical placebo, both for up to 14 days.

Remdesivir was developed by Gilead Sciences, Inc. Baricitinib was developed by Eli Lilly and Company.

Albert Einstein College of Medicine

Journal reference:

Beigel, J.H., et al. (2020) Remdesivir for the Treatment of Covid-19 — Preliminary Report. New England Journal of Medicine. doi.org/10.1056/NEJMoa2007764.

Source: | Medical News

Source: Sound Health and Lasting Wealth

The post Montefiore and Einstein evaluate a new drug combination to fight COVID-19 appeared first on NewsColony.
NewsColony

source https://newscolony.com/montefiore-and-einstein-evaluate-a-new-drug-combination-to-fight-covid-19/

Volunteers book hotel room for homeless man with SingapoRediscovers vouchers

NewsColony Volunteers book hotel room for homeless man with SingapoRediscovers vouchers © The Independent Singapore Singapore — A group of volunteers from the Mummy Yummy Singapore welfare organisation donated their SingapoRediscovers Vouchers to book a hotel room for a homeless man. The man, who was identified as Jayden, did not have a place to live while waiting for the Housing Board (HDB) to allocate him a rental flat. In a Facebook post on Mummy Yummy Singapore’s page on Wednesday (Dec 16), the volunteers said: “We used our $100 Rediscover Singapore vouchers to redeem hotel stay for him and successfully booked 9 days worth of stay at 3 days per voucher.” They added that they were unable to book a longer stay because of higher hotel rates over Christmas and New Year. The volunteers hoped that they would be able to bridge Jayden’s stay until he got a flat. “Thanks our government for giving us these vouchers which in return we can put them to good use for people in need,” th...

17 gifts from Oprah’s Favorite Things you can get by Christmas

NewsColony 17 gifts from Oprah’s Favorite Things you can get by Christmas (CNN) — Oprah Winfrey has pretty impeccable taste, and this year, she’s gifted us once again with her Favorite Things list, available to shop via Amazon . We’ve gone through and pulled out some of our own favorite picks from the list, which features products for everyone on your holiday gift list at a range of prices. And while, obviously, it’s Oprah, so everything included is great, we especially love her picks from Black- and female-owned small businesses. Check out our top gift picks below, and browse all of Oprah’s Favorite Things on Amazon. Iconi Women’s Seamless High-Waisted Leggings ($45; amazon.com ) Iconi Women’s Seamless High-Waisted Leggings PHOTO: Amazon These comfortable leggings are designed to be everything you’ve always wanted in a pair: moisture-wicking, supportive and squatproof. Plus, they come in a ton of pretty heathered colors. “A Kids Book About…” ($15.96; amazon.c...

Disabled people are still vulnerable, even as COVID-19 normalizes their ‘special’ needs

Disabled people are still vulnerable, even as COVID-19 normalizes their ‘special’ needs NewsColony Perhaps it’s appropriate that public notices of the COVID-19 crisis began as an ableist cruelty. Health officials assured the nation that only the elderly and those with chronic health conditions would be seriously affected; most Americans (i.e., the normal people) would have only mild symptoms and be fine. x A friendly reminder: people who will be high-risk patients if we get coronavirus can hear you when you reassure everyone we’re the only ones who might die. Ã¢Â€Â” Alexandra Brodsky (@azbrodsky) February 29, 2020 Soon after the announcement of those assurances, the likelihood of high-risk people surviving was further limited by the people more likely to be fine. Shopping frenzies cleared stores of essential supplies needed everyday by many disabled people, like thermometers, hand wipes, masks, and IV infusion supplies. Accustomed to their needs ...

NewsColony

Search This Blog